US Stock MarketDetailed Quotes

HRMY Harmony Biosciences

Watchlist
  • 34.280
  • +0.390+1.15%
Close Dec 20 16:00 ET
  • 34.280
  • 0.0000.00%
Post 16:20 ET
1.96BMarket Cap16.25P/E (TTM)

Harmony Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
11.73%70.5M
14.99%42.62M
-26.83%31.14M
51.86%219.39M
187.37%76.67M
14.30%63.1M
9.88%37.06M
47.51%42.56M
46.58%144.47M
-28.92%26.68M
Net income from continuing operations
19.84%46.09M
-66.21%11.59M
30.01%38.33M
-28.99%128.85M
-45.15%26.61M
-56.27%38.46M
45.77%34.3M
37.24%29.49M
424.52%181.47M
113.56%48.51M
Operating gains losses
----
----
----
--9.77M
--0
----
----
----
----
----
Depreciation and amortization
-2.26%5.97M
-0.20%6.05M
0.99%6.12M
4.17%24.36M
0.94%6.13M
0.71%6.11M
0.15%6.06M
16.64%6.06M
24.12%23.39M
27.48%6.07M
Deferred tax
30.07%-4.83M
-240.54%-14.28M
-1.02%-3.48M
84.39%-13.42M
126.34%1.12M
91.54%-6.91M
---4.19M
---3.44M
---85.94M
---4.26M
Other non cash items
-36.20%1.07M
4,234.83%43.31M
380.42%687K
48.00%5.8M
126.80%2.99M
157.54%1.67M
12.37%999K
-86.57%143K
46.09%3.92M
520.77%1.32M
Change In working capital
73.96%11.7M
-105.03%-14.51M
-643.21%-20.33M
953.26%35.04M
199.57%31.64M
-80.90%6.73M
-76.01%-7.08M
206.16%3.74M
-750.71%-4.11M
-614.74%-31.78M
-Change in receivables
147.94%1.66M
69.40%-3.44M
-357.69%-5.58M
2.50%-19.4M
-2,215.69%-6.88M
34.16%-3.45M
3.87%-11.24M
165.81%2.17M
-57.08%-19.9M
119.85%325K
-Change in inventory
-445.92%-1.27M
128.01%214K
-338.65%-494K
-889.63%-1.07M
30.48%-276K
-175.65%-233K
-296.40%-764K
225.45%207K
122.17%135K
-206.43%-397K
-Change in prepaid assets
78.75%-847K
-134.56%-565K
-680.91%-3.44M
100.98%74K
164.45%1.83M
-299.80%-3.99M
211.07%1.64M
126.49%592K
-356.07%-7.55M
-238.06%-2.84M
-Change in payables and accrued expense
-50,529.17%-12.15M
4,021.48%6.14M
-198.40%-2.59M
137.33%55.43M
282.49%52.68M
-100.06%-24K
-98.30%149K
13.42%2.63M
48.68%23.36M
-621.01%-28.86M
-Change in other current liabilities
68.61%24.32M
-637.48%-16.87M
-344.81%-8.23M
99.34%-1K
---15.71M
1,442,200.00%14.42M
--3.14M
-1,117.11%-1.85M
-3.42%-151K
--0
Cash from discontinued investing activities
Operating cash flow
11.73%70.5M
14.99%42.62M
-26.83%31.14M
51.86%219.39M
187.37%76.67M
14.30%63.1M
9.88%37.06M
47.51%42.56M
46.58%144.47M
-28.92%26.68M
Investing cash flow
Cash flow from continuing investing activities
191.64%745K
-605.91%-54.86M
-245.59%-6.19M
67.26%-46.44M
23.09%-36.07M
97.49%-813K
65.38%-7.77M
95.53%-1.79M
-41.41%-141.83M
-46.9M
Net PPE purchase and sale
---3K
-208.29%-632K
---5K
-81.40%-312K
---107K
--0
-400.00%-205K
--0
42.28%-172K
--0
Net intangibles purchase and sale
----
----
----
--0
----
----
----
----
60.00%-40M
--0
Net business purchase and sale
--0
----
----
---36.97M
---36.97M
--0
----
----
--0
----
Net investment purchase and sale
192.00%748K
157.43%4.35M
-245.31%-6.18M
90.99%-9.16M
102.15%1.01M
97.49%-813K
66.23%-7.57M
---1.79M
---101.66M
---46.9M
Net other investing changes
--0
----
----
----
----
----
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
191.64%745K
-605.91%-54.86M
-245.59%-6.19M
67.26%-46.44M
23.09%-36.07M
97.49%-813K
65.38%-7.77M
95.53%-1.79M
-41.41%-141.83M
---46.9M
Financing cash flow
Cash flow from continuing financing activities
97.87%-1.18M
-916.52%-3.45M
-206.60%-3.63M
-1,642.93%-105.55M
-2,113.66%-53.52M
-2,787.76%-55.1M
-145.20%-339K
146.49%3.41M
-7.79%6.84M
-62.42%2.66M
Net issuance payments of debt
-101.88%-3.75M
-650.00%-3.75M
-650.00%-3.75M
37.50%-1.25M
-39,950.00%-200.25M
40,100.00%200M
0.00%-500K
0.00%-500K
-300.00%-2M
-102.33%-500K
Net common stock issuance
----
----
----
---100M
-12,154.90%-50M
----
----
----
--0
---408K
Proceeds from stock option exercised by employees
955.33%2.58M
-15.11%573K
-97.03%116K
-42.82%5.06M
-93.63%227K
-88.61%244K
-46.00%675K
107.59%3.91M
-5.66%8.84M
-52.94%3.57M
Net other financing activities
--0
----
----
---9.36M
--196.5M
---205.34M
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
97.87%-1.18M
-916.52%-3.45M
-206.60%-3.63M
-1,642.93%-105.55M
-2,113.66%-53.52M
-2,787.76%-55.1M
-145.20%-339K
146.49%3.41M
-7.79%6.84M
-62.42%2.66M
Net cash flow
Beginning cash position
-0.03%317.57M
15.43%333.25M
27.56%311.93M
4.03%244.53M
23.95%324.85M
33.88%317.67M
28.17%288.71M
4.03%244.53M
2.48%235.06M
37.61%262.09M
Current changes in cash
874.83%70.07M
-154.17%-15.69M
-51.74%21.32M
611.30%67.4M
26.40%-12.92M
-71.03%7.19M
140.59%28.95M
550.34%44.18M
66.87%9.48M
-139.37%-17.56M
End cash Position
19.33%387.64M
-0.03%317.57M
15.43%333.25M
27.56%311.93M
27.56%311.93M
23.95%324.85M
33.88%317.67M
28.17%288.71M
4.03%244.53M
4.03%244.53M
Free cash flow
11.72%70.5M
13.91%41.99M
-26.84%31.14M
110.06%219.08M
186.97%76.56M
14.48%63.1M
9.40%36.86M
480.23%42.56M
6,090.47%104.29M
-28.92%26.68M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 11.73%70.5M14.99%42.62M-26.83%31.14M51.86%219.39M187.37%76.67M14.30%63.1M9.88%37.06M47.51%42.56M46.58%144.47M-28.92%26.68M
Net income from continuing operations 19.84%46.09M-66.21%11.59M30.01%38.33M-28.99%128.85M-45.15%26.61M-56.27%38.46M45.77%34.3M37.24%29.49M424.52%181.47M113.56%48.51M
Operating gains losses --------------9.77M--0--------------------
Depreciation and amortization -2.26%5.97M-0.20%6.05M0.99%6.12M4.17%24.36M0.94%6.13M0.71%6.11M0.15%6.06M16.64%6.06M24.12%23.39M27.48%6.07M
Deferred tax 30.07%-4.83M-240.54%-14.28M-1.02%-3.48M84.39%-13.42M126.34%1.12M91.54%-6.91M---4.19M---3.44M---85.94M---4.26M
Other non cash items -36.20%1.07M4,234.83%43.31M380.42%687K48.00%5.8M126.80%2.99M157.54%1.67M12.37%999K-86.57%143K46.09%3.92M520.77%1.32M
Change In working capital 73.96%11.7M-105.03%-14.51M-643.21%-20.33M953.26%35.04M199.57%31.64M-80.90%6.73M-76.01%-7.08M206.16%3.74M-750.71%-4.11M-614.74%-31.78M
-Change in receivables 147.94%1.66M69.40%-3.44M-357.69%-5.58M2.50%-19.4M-2,215.69%-6.88M34.16%-3.45M3.87%-11.24M165.81%2.17M-57.08%-19.9M119.85%325K
-Change in inventory -445.92%-1.27M128.01%214K-338.65%-494K-889.63%-1.07M30.48%-276K-175.65%-233K-296.40%-764K225.45%207K122.17%135K-206.43%-397K
-Change in prepaid assets 78.75%-847K-134.56%-565K-680.91%-3.44M100.98%74K164.45%1.83M-299.80%-3.99M211.07%1.64M126.49%592K-356.07%-7.55M-238.06%-2.84M
-Change in payables and accrued expense -50,529.17%-12.15M4,021.48%6.14M-198.40%-2.59M137.33%55.43M282.49%52.68M-100.06%-24K-98.30%149K13.42%2.63M48.68%23.36M-621.01%-28.86M
-Change in other current liabilities 68.61%24.32M-637.48%-16.87M-344.81%-8.23M99.34%-1K---15.71M1,442,200.00%14.42M--3.14M-1,117.11%-1.85M-3.42%-151K--0
Cash from discontinued investing activities
Operating cash flow 11.73%70.5M14.99%42.62M-26.83%31.14M51.86%219.39M187.37%76.67M14.30%63.1M9.88%37.06M47.51%42.56M46.58%144.47M-28.92%26.68M
Investing cash flow
Cash flow from continuing investing activities 191.64%745K-605.91%-54.86M-245.59%-6.19M67.26%-46.44M23.09%-36.07M97.49%-813K65.38%-7.77M95.53%-1.79M-41.41%-141.83M-46.9M
Net PPE purchase and sale ---3K-208.29%-632K---5K-81.40%-312K---107K--0-400.00%-205K--042.28%-172K--0
Net intangibles purchase and sale --------------0----------------60.00%-40M--0
Net business purchase and sale --0-----------36.97M---36.97M--0----------0----
Net investment purchase and sale 192.00%748K157.43%4.35M-245.31%-6.18M90.99%-9.16M102.15%1.01M97.49%-813K66.23%-7.57M---1.79M---101.66M---46.9M
Net other investing changes --0------------------------------------
Cash from discontinued investing activities
Investing cash flow 191.64%745K-605.91%-54.86M-245.59%-6.19M67.26%-46.44M23.09%-36.07M97.49%-813K65.38%-7.77M95.53%-1.79M-41.41%-141.83M---46.9M
Financing cash flow
Cash flow from continuing financing activities 97.87%-1.18M-916.52%-3.45M-206.60%-3.63M-1,642.93%-105.55M-2,113.66%-53.52M-2,787.76%-55.1M-145.20%-339K146.49%3.41M-7.79%6.84M-62.42%2.66M
Net issuance payments of debt -101.88%-3.75M-650.00%-3.75M-650.00%-3.75M37.50%-1.25M-39,950.00%-200.25M40,100.00%200M0.00%-500K0.00%-500K-300.00%-2M-102.33%-500K
Net common stock issuance ---------------100M-12,154.90%-50M--------------0---408K
Proceeds from stock option exercised by employees 955.33%2.58M-15.11%573K-97.03%116K-42.82%5.06M-93.63%227K-88.61%244K-46.00%675K107.59%3.91M-5.66%8.84M-52.94%3.57M
Net other financing activities --0-----------9.36M--196.5M---205.34M----------------
Cash from discontinued financing activities
Financing cash flow 97.87%-1.18M-916.52%-3.45M-206.60%-3.63M-1,642.93%-105.55M-2,113.66%-53.52M-2,787.76%-55.1M-145.20%-339K146.49%3.41M-7.79%6.84M-62.42%2.66M
Net cash flow
Beginning cash position -0.03%317.57M15.43%333.25M27.56%311.93M4.03%244.53M23.95%324.85M33.88%317.67M28.17%288.71M4.03%244.53M2.48%235.06M37.61%262.09M
Current changes in cash 874.83%70.07M-154.17%-15.69M-51.74%21.32M611.30%67.4M26.40%-12.92M-71.03%7.19M140.59%28.95M550.34%44.18M66.87%9.48M-139.37%-17.56M
End cash Position 19.33%387.64M-0.03%317.57M15.43%333.25M27.56%311.93M27.56%311.93M23.95%324.85M33.88%317.67M28.17%288.71M4.03%244.53M4.03%244.53M
Free cash flow 11.72%70.5M13.91%41.99M-26.84%31.14M110.06%219.08M186.97%76.56M14.48%63.1M9.40%36.86M480.23%42.56M6,090.47%104.29M-28.92%26.68M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Heat List
US
Overall
Symbol
Price
% Chg

No Data